×
For best experience we recommend to activate Javascript in your browser.
Tuberin antibody (pSer664)
The Rabbit Polyclonal anti-Tuberin antibody has been validated for DB and IF/ICC. It is suitable to detect Tuberin in samples from Human.
Quick Overview for Tuberin antibody (pSer664) (ABIN3001820)
Target
See all Tuberin (TSC2) Antibodies
Tuberin (TSC2)
(Tuberous Sclerosis 2 (TSC2))
Reactivity
All reactivities for Tuberin antibodies
Human
Host
All hosts for Tuberin antibodies
Rabbit
Clonality
All clonalities for Tuberin antibodies
Polyclonal
Conjugate
All conjugates for Tuberin antibodies
This Tuberin antibody is un-conjugated
Application
All applications for Tuberin antibodies
Dot Blot (DB), Immunofluorescence (fixed cells) (IF/ICC)
Product Details anti-Tuberin Antibody
(hide)
Binding Specificity
All epitopes for Tuberin antibodies
pSer664
Purification
This antibody is first purified by protein A affinity chromatography. Then, the antibody fraction is peptide affinity purified in a 2-step procedure with peptides. The antibody is eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Immunogen
Human TSC2 (phospho-Ser664).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Target Details for Tuberin
(hide)
Target
Tuberin (TSC2)
(Tuberous Sclerosis 2 (TSC2))
Alternative Name
TSC2
UniProt
P49815
Pathways
RTK Signaling , AMPK Signaling , Fc-epsilon Receptor Signaling Pathway , EGFR Signaling Pathway , Neurotrophin Signaling Pathway , Regulation of Cell Size , Tube Formation , Protein targeting to Nucleus
Recently viewed
(hide)
Chat with us , powered by LiveChat